MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/clt2.12390

Медицинская библиотека · Clinical and translational allergy · 2024

Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®.

Bousquet Jean, Sousa-Pinto Bernardo, Anto Josep M, Bedbrook Anna, Czarlewski Wienczyslawa, Ansotegui Ignacio J, Bergmann Karl-C, Braido Fulvio, Brussino Luisa, Cecchi Lorenzo, Loureiro Claudia Chaves, Cruz Alvaro A, Devillier Philippe, Fiocchi Alessandro, Gemicioglu Bilun, Haahtela Tari, Ivancevich Juan Carlos, Klimek Ludger, Kulus Marek, Kuna Piotr, Kupczyk Maciej, Kvedariene Violeta, Larenas-Linnemann Desiree E, Louis Gilles, Louis Renaud, Makris Michael, Morais-Almeida Mario, Niedoszytko Marek, Ohta Ken, Ollert Markus, Papadopoulos Nikolaos, Patella Vincenzo, Pétré Benoit, Pfaar Oliver, Puggioni Francesca, Quirce Santiago, Regateiro Frederico S, Roche Nicolas, Rouadi Philip W, Samolinski Boleslaw, Sastre Joaquin, Schleich Florence, Scichilone Nicola, Taborda-Barata Luis, Toppila-Salmi Sanna, Valiulis Arunas, Vardaloglu Koyuncu Ilgim, Ventura Maria Teresa, Yorgancioglu Arzu, Fonseca Joao A, Zuberbier Torsten

СтатьяПеревод в очереди

Аннотация

Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.

Для цитирования: Bousquet Jean, Sousa-Pinto Bernardo, Anto Josep M, Bedbrook Anna, Czarlewski Wienczyslawa, Ansotegui Ignacio J, Bergmann Karl-C, Braido Fulvio, Brussino Luisa, Cecchi Lorenzo, Loureiro Claudia Chaves, Cruz Alvaro A, Devillier Philippe, Fiocchi Alessandro, Gemicioglu Bilun, Haahtela Tari, Ivancevich Juan Carlos, Klimek Ludger, Kulus Marek, Kuna Piotr, Kupczyk Maciej, Kvedariene Violeta, Larenas-Linnemann Desiree E, Louis Gilles, Louis Renaud, Makris Michael, Morais-Almeida Mario, Niedoszytko Marek, Ohta Ken, Ollert Markus, Papadopoulos Nikolaos, Patella Vincenzo, Pétré Benoit, Pfaar Oliver, Puggioni Francesca, Quirce Santiago, Regateiro Frederico S, Roche Nicolas, Rouadi Philip W, Samolinski Boleslaw, Sastre Joaquin, Schleich Florence, Scichilone Nicola, Taborda-Barata Luis, Toppila-Salmi Sanna, Valiulis Arunas, Vardaloglu Koyuncu Ilgim, Ventura Maria Teresa, Yorgancioglu Arzu, Fonseca Joao A, Zuberbier Torsten. Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®.. Clinical and translational allergy. 2024. DOI: 10.1002/clt2.12390.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.